Success Metrics

Clinical Success Rate
70.0%

Based on 7 completed trials

Completion Rate
70%(7/10)
Active Trials
0(0%)
Results Posted
129%(9 trials)
Terminated
3(23%)

Phase Distribution

Ph not_applicable
2
15%
Ph phase_2
1
8%
Ph phase_4
10
77%

Phase Distribution

0

Early Stage

1

Mid Stage

10

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
Phase 4Post-market surveillance
10(76.9%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(7)
Terminated(3)
Other(3)

Detailed Status

Completed7
Terminated3
unknown3

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
70.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.7%)
Phase 410 (76.9%)
N/A2 (15.4%)

Trials by Status

terminated323%
completed754%
unknown323%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DRUG
Total Trials
13